Cargando…

2422. Efficacy of Cefoxitin for the Treatment of Urinary Tract Infection (UTI) Due to ESBL-Producing E. coli and K. pneumoniae Isolates

BACKGROUND: Cefoxitin has a good in vitro activity and stability in resistance to hydrolysis by ESBLs, and is a good candidate for the treatment of urinary tract infection (UTI). However, data are scarce regarding its use in clinical practice, especially against K. pneumoniae deemed to be capable of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Senard, Olivia, Bouchand, Frederique, Deconinck, Laurene, Matt, Morgan, Fellous, Lesly, Rottman, Martin, Perronne, Christian, Dinh, Aurelien, Davido, Benjamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253686/ http://dx.doi.org/10.1093/ofid/ofy210.2075

Ejemplares similares

Efficacy of cefoxitin for the treatment of urinary tract infection due to extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates
por: Senard, Olivia, et al.
Publicado: (2018)

Efficacy of cotrimoxazole (Sulfamethoxazole-Trimethoprim) as a salvage therapy for the treatment of bone and joint infections (BJIs)
por: Deconinck, Laurene, et al.
Publicado: (2019)

Germs of thrones - spontaneous decolonization of Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococci (VRE) in Western Europe: is this myth or reality?
por: Davido, Benjamin, et al.
Publicado: (2018)

Impact of Fecal Microbiota Transplantation on Digestive Tract Colonization due to Carbapenem-resistant Enterobacteriacae and Vancomycin-resistant Enterococci
por: Davido, Benjamin, et al.
Publicado: (2017)

Impact of Anti-Inflammatory Drugs on Pyogenic Vertebral Osteomyelitis: A Prospective Cohort Study
por: Dinh, Aurélien, et al.
Publicado: (2016)

Stenotrophomonas maltophilia: Complicating treatment of ESBL UTI
por: Kumar, Simit, et al.
Publicado: (2015)

Assessing clinical cure of empirical piperacillin/tazobactam for ESBL urinary tract infections (ACCEPT—UTI)
por: Stefanos, Sylvia S, et al.
Publicado: (2023)

Subcutaneous Phaeohyphomycosis Due to Pyrenochaeta romeroi Mimicking a Synovial Cyst
por: Dinh, Aurélien, et al.
Publicado: (2016)

Risk Factors for Community Acquired Extended-Spectrum Β-lactamase (ESBL) Producing Enterobacteriaceae Urinary Tract Infections (UTIs)
por: Goyal, Dheeraj, et al.
Publicado: (2017)

Factors Associated With Treatment Failure in Moderately Severe Community-Acquired Pneumonia: A Secondary Analysis of a Randomized Clinical Trial
por: Dinh, Aurélien, et al.
Publicado: (2021)

Re-evaluation of cefepime or piperacillin/tazobactam to decrease use of carbapenems in ESBL-producing Enterobacterales urinary tract infections (REDUCE-UTI)
por: Branton, Alexander C, et al.
Publicado: (2023)

Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over time
por: Davido, Benjamin, et al.
Publicado: (2020)

Machine learning model for predicting ciprofloxacin resistance and presence of ESBL in patients with UTI in the ED
por: Lee, Hyun-Gyu, et al.
Publicado: (2023)

477. Characterization of Extended-Spectrum Β-Lactamase (ESBL) Producing Gram-negative (GN) Urinary Tract Infections (UTI) in Pediatric Patients
por: Stach, Leslie, et al.
Publicado: (2019)

1257. Re-Evaluation of Cefepime or Piperacillin-Tazobactam to Decrease Use of Carbapenems in ESBL-Producing Enterobacterales Urinary Tract Infections (REDUCE-UTI)
por: Branton, Alexander C, et al.
Publicado: (2021)

2422: Magnetic nanoparticles facilitate tracking of dendritic cells for treatment of malignant brain tumors
por: Grippin, Adam, et al.
Publicado: (2018)

Management of febrile urinary tract infection among spinal cord injured patients
por: Dinh, Aurélien, et al.
Publicado: (2016)

2826. Epidemiology of Extended Spectrum Beta-lactamase (ESBL)-producing Enterobacterales and Antimicrobial Resistance in Urinary Tract Infection (UTI) and Acute Pyelonephritis (AP)
por: Fernandez, Maria, et al.
Publicado: (2023)

Factors associated with bacteraemia due to multidrug-resistant organisms among bacteraemic patients with multidrug-resistant organism carriage: a case control study
por: Mascitti, Hélène, et al.
Publicado: (2018)

260 Ceftolozane/Tazobactam for the Treatment of cUTI and cIAI Caused by ESBL-producing Enterobacteriaceae
por: Popejoy, Myra, et al.
Publicado: (2014)

Management and characteristics of patients suffering from Clostridiodes difficile infection in primary care
por: Klezovich-Bénard, Maria, et al.
Publicado: (2021)

Compassionate Use of Cefiderocol to Treat a Case of Prosthetic Joint Infection Due to Extensively Drug-Resistant Enterobacter hormaechei
por: Siméon, Soline, et al.
Publicado: (2020)

One Base Deletion (c.2422delT) in the TPO Gene Causes Severe Congenital Hypothyroidism
por: Cangül, Hakan, et al.
Publicado: (2014)

Ampicillin/Sulbactam Vs. Cefoxitin for the Treatment of Pelvic Inflammatory Disease
por: Jemsek, Joseph G., et al.
Publicado: (1997)

Cefoxitin vs. Piperacillin/Tazobactam for Acute Appendicitis in Pediatric Patients
por: Paek, Hana, et al.
Publicado: (2017)

Antibiotic Susceptibilities and Appropriateness of Initial Drug Selection for Community-Acquired Urinary Tract Infections (UTI) Caused by Extended-Spectrum Β-Lactamase (ESBL)-Producing Pathogens
por: Lee, Stephen, et al.
Publicado: (2017)

Phalloplasty Complicated by Penile Artery Thrombosis, Recurrent Extended-Spectrum Beta-Lactamase (ESBL) Urinary Tract Infection (UTI), Colovesical Fistula, and Enterococcus Faecalis Endocarditis
por: Gilbert, Zachary, et al.
Publicado: (2021)

A Restructured Hospital Into a One-Building Organization for COVID-19 Patients: A Resilient and Effective Response to the Pandemic
por: Bessis, Simon, et al.
Publicado: (2022)

2422. Relative Risk of Patients Having a Catheter-Associated Urinary Tract Infection Within 7 days of Having an Indwelling Urinary Catheter Reinserted Within 24 Hours of Indwelling Urinary Catheter Removal
por: Hadhazy, Eric, et al.
Publicado: (2023)

Analyse des consommations locales d’antibiotiques durant la première vague épidémique de COVID-19 (mars–avril 2020) dans un hôpital de référence
por: Roquefeuil, L., et al.
Publicado: (2021)

Role of SCCmec type in resistance to the synergistic activity of oxacillin and cefoxitin in MRSA
por: Reichmann, Nathalie T., et al.
Publicado: (2017)

Evaluation of in-house cefoxitin screening broth to determine methicillin-resistant staphylococci
por: Saenhom, Natkamon, et al.
Publicado: (2022)

Detection of Oxacillin/Cefoxitin Resistance in Staphylococcus aureus Present in Recurrent Tonsillitis
por: Messias, Aline Cristine Magalhães Costa, et al.
Publicado: (2023)

Frailty associated urinary tract infections (FaUTIs)
por: Kostakopoulos, Nikolaos A., et al.
Publicado: (2021)

Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study
por: Chabert, Paul, et al.
Publicado: (2022)

Clinical Cutaneous Features of Patients Infected With SARS-CoV-2 Hospitalized for Pneumonia: A Cross-sectional Study
por: Mascitti, Hélène, et al.
Publicado: (2020)

Prevalence and molecular characteristics of ESBL and AmpC β -lactamase producing Enterobacteriaceae strains isolated from UTIs in Egypt
por: Mohamed, Ebtisam S., et al.
Publicado: (2020)

Case–control Study Evaluating Risk Factors and Treatment Outcomes for Community-Acquired Urinary Tract Infections (UTI) Caused by Extended-Spectrum Β-Lactamase (ESBL)-Producing Pathogens
por: Lee, Stephen, et al.
Publicado: (2017)

Antibiotic Consumption and Bacterial Resistance Rates in Hospitalized COVID-19 Patients: A Retrospective Study During the 3 First Surges
por: Jaffal, Karim, et al.
Publicado: (2022)

Single-Blind, Prospective, Randomized Study of Cefmetazole and Cefoxitin in the Treatment of Postcesarean Endometritis
por: Chatwani, Ashwin, et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_2u8jqs7j8gful8nhv39nhv3c1f